Stonebridge Capital Management’s Pfizer PFE Stock Holding History

Stonebridge Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Buy	+50,489	New	+$1.34M	0.64%	37
2025 Q2	$1.56M	Sell	64,559 -2,560	-4%	-$59.7K	0.61%	37
2025 Q1	$1.7M	Sell	67,119 -4,840	-7%	-$127K	0.74%	33
2024 Q4	$1.91M	Sell	71,959 -2,305	-3%	-$62.5K	0.78%	32
2024 Q3	$2.15M	Sell	74,264 -341	-0.5%	-$9.95K	0.85%	32
2024 Q2	$2.09M	Sell	74,605 -155	-0.2%	-$4.27K	0.89%	32
2024 Q1	$2.08M	Sell	74,760 -3,593	-5%	-$99.7K	0.93%	33
2023 Q4	$2.26M	Buy	+78,353	New	+$2.37M	1.1%	27

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Stonebridge Capital Management's PFE Position: Q1 2026 in Review

Stonebridge Capital Management opened a new position in Pfizer (PFE) in Q1 2026: 50,489 shares worth $1.42M. The stake represents 0.64% of the portfolio and ranks #37 among its holdings. This is a return to the name: Stonebridge Capital Management previously reported a position in PFE as recently as Q2 2025.

Stonebridge Capital Management first reported a position in PFE in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.26M in Q4 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Stonebridge Capital Management held 50,489 shares of Pfizer worth $1.42M as of Q1 2026.
Pfizer was a new Stonebridge Capital Management position in Q1 2026.
Pfizer made up 0.64% of Stonebridge Capital Management's portfolio in Q1 2026, its #37 holding.
Stonebridge Capital Management first reported a position in Pfizer in Q4 2023 and has held it in 8 quarters since.
Stonebridge Capital Management's Pfizer position peaked at $2.26M in Q4 2023.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Stonebridge Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.